Buyer for pharma manufacturing site in Europe

Company to buy

• Size: medium-sized business
• Revenue: 3-50 M EUR
• Location of the target company: Europe.
• Reason for acquisition: The company wants to enhance its portfolio and expand on several markets wordwide. 
• #CFIE PHB032

Overview of the pharmaceutical manufacturing unit wanted

This buyer is looking for a new acquisition worldwide. The company is interested to acquire pharmaceutical distribution firm that has products for treatment of acute and chronic conditions in form of tablets and capsules such as oral solid dose, liquids, semi-solids and others. The company should preferably generates sustainable revenue and should have a potential growth.  

Profile (strategy) of pharmaceutical manufacturing buyer

A large company with more than 2500 employees in more than 100 countries, focusing on branded and generic pharmaceuticals with basket of products that provide treatment for acute and chronic conditions. Are in which the company operates: thrombosis, anesthetics, high potency & cytotoxic and nutritionals. The company holds international manufacturing approvals from regulatory agencies such as the United States Food and Drug Administration, the Australian Therapeutic Goods Administration and the European Directorate for the Quality of Medicines. Manufacturing products include: oral solid dose, liquids, semi-solids, sterile, biologicals, active pharmaceutical ingredients and nutritionals.

Activities and products of the target pharmaceutical manufacturing unit

The buyer is now looking for a company with products that provide treatment for a broad spectrum of acute and chronic conditions experienced through all stages of life. Preferred company has experiences with manufacturing products such as oral solid dose, liquids, semi-solids, sterile, biologicals, active pharmaceutical ingredients and nutritionals.

Operates in thrombosis, anesthetics, high potency & cytotoxic or nutritionals areas. 

The goal of the buyer is to acquire profitable manufacturing pharma company with EBITDA in the range of 3-50 million euros. 

Highlights of the pharmaceutical manufacturing buyer

• A large generic and branded pharmaceutical company with intensive M&A activities. 
• The buyer is interested in branded and generic pharmaceutical companies that have products for treatment of acute and chronic conditions.
• Desired company operates in thrombosis, anaesthetics, high potency & cytotoxics or nutritionals areas. 
• Has experiences with manufacturing products such as oral solid dose, liquids, semi-solids, steriles, biologicals, active pharmaceutical ingredients and nutritionals.

Information about this buyer of pharmaceutical manufacturing firm 

Feel free to contact us for more information regarding this pharmaceutical manufacturing firm wanted in Europe or if you know possible interested or suited parties. For more buyers of pharmaceutical manufacturing firm, please visit the section pharmaceutical company wanted. For pharmaceutical manufacturing firm for sale the section pharmaceutical company for sale.

Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.